Chapter 1. An Introduction to Malnutrition in the Intensive Care Unit
David S. Seres
Chapter 2. The Immunological Role of Nutrition in the Gut
Rebecca A. Busch and Kenneth A. Kudsk
Chapter 3. Assessment of the Patient
Marion F. Winkler, Kenneth A. Lynch, Jr., and Stephanie N. Lueckel
Chapter 4. Timing and Indications for Enteral Nutrition in the Critically Ill
Philippa T. Heighes, Gordon S. Doig, and Fiona Simpson
Chapter 5. Access and Complications of Enteral Nutrition Support for Critically Ill Patients
Tushar D. Gohel and Donald F. Kirby
Chapter 6. Timing and Indication for Parenteral Nutrition in the Critically Ill
Jan Gunst and Michael P. Casaer
Chapter 7. Access and Complications of Parenteral Nutrition
Dustin R. Neel
Chapter 8. Surgical Intensive Care Considerations
Charles W. Van Way, III
Chapter 9. Major Infections and Sepsis
Eoin Slattery and David S. Seres
Chapter 10. Organ Failure and Specialized Enteral Formulas
Ainsley Malone and Farshad Farnejad
Chapter 11. Management of the Obese Patient
Roland N. Dickerson
Chapter 12. Ethical Considerations in Nutrition Support in Critical Care
Albert Barrocas and Denise Baird Schwartz
Chapter 13. Safe Practices for Enteral and Parenteral Nutrition
Joseph I. Boullata
Chapter 14. The Economic Impact of Nutrition Support, and the Multidisciplinary Approach
Robert DeChicco and Ezra Steiger
Chapter 15. Microbiome in the Critically Ill
Meredith Barrett and Daniel H. Teitelbaum
Chapter 16. Future Research
David S. Seres and Charles W. Van Way, III
About the Author: Dr. Seres is the Director of Medical Nutrition at Columbia University Medical Center. He is one of the few physicians in the country with a primary focus on hospital based nutrition. He supervises the hospital programs in total parenteral nutrition, manages much of the hospital supplementary enteral nutrition, and provides consultation on feeding issues and malnutrition. Dr. Van Way s activities have centered around hemorrhagic shock, and to exploring the basic mechanisms of cell injury during hemorrhagic shock and resuscitation, and to identify changes which produce long-term damage. In the past several years, his research team has carried out basic and clinical studies of the genomic response to shock and injury, and has developed several potential therapeutic agents for the treatment of hemorrhagic shock. Currently, his team is exploring the mechanisms by which cells adjust to the low-oxygen environments which characterize low perfusion states such as septic and hemorrhagic shock."
